Epigallocathecingallate (EGCG) antifungal properties for candida isolates from HIV/AIDS patients with oral candidiasis in compare with fluconazole

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Background: Oral Candidiasis (OC) still mainly oportunistic infection problem in HIV/AIDS Patients. Due to increasing report of fluconazole resistant as common antifungal drugs nowadays, there have been many studies focusing on natural substances and its antifungal properties. In this study, a form of green tea extract, named Epigallocathechingallate (EGCG) 1,25% were examined for their in vitro antifungal activity against Candida sp in comparison to fluconazole (2 mg/ml) as standard antifungal agents.Objective: To evaluate the antifungal activity of EGCG in compare with fluconazole against Candida isolates taken from HIV / AIDS patients with OC. Methods: Fourty Candida sp. isolates taken from HIV / AIDS patients with OC in the Outpatient Unit and Inpatient Installation of the Infectious Disease Intermediate Care Unit (UPIPI) Dr. Soetomo, Surabaya. Antifungal activity were evaluated by using microdilution tests. Results: The microdilution test revealed the MIC of EGCG for all Candida sp. was 0.625%, while the MIC of fluconazole was 100% for all Candida sp. There was significant difference (p <0.05) between the MIC values for Candida sp. by fluconazole and EGCG. The MFC values of EGCG was 50%, while value of fluconazole MFC was 100%. Conclusion: Antifungal activity of EGCG with fungistatic and fungicidal effect is better than fluconazole.

Original languageEnglish
Pages (from-to)1027-1029
Number of pages3
JournalIndian Journal of Forensic Medicine and Toxicology
Volume15
Issue number1
DOIs
Publication statusPublished - 1 Jan 2021

Keywords

  • Antifungal activity
  • Candida albicans
  • Candida non-albicans
  • EGCG
  • Fluconazole
  • HIV/AIDS
  • Oral candidiasis

Fingerprint

Dive into the research topics of 'Epigallocathecingallate (EGCG) antifungal properties for candida isolates from HIV/AIDS patients with oral candidiasis in compare with fluconazole'. Together they form a unique fingerprint.

Cite this